
Validea’s guru fundamental report ranks Mastercard highest under its Patient Investor (Warren Buffett) model, giving the large-cap consumer-financials stock an 86% score out of 22 strategies; the company passes key quality and capital-allocation tests—including earnings predictability, ROE, ROA, free cash flow, retained earnings use, and buybacks—but fails the initial rate-of-return screen, indicating a potentially rich entry valuation. This profile suggests Mastercard fits Buffett-style criteria for durable profitability and conservative capital deployment and may be suitable for long-term institutional allocations, although the failed initial return metric tempers near-term return expectations.
Validea's guru fundamental report ranks Mastercard (MA) highest among its 22 strategies under the Patient Investor (Warren Buffett) model, assigning an 86% score that signals strategy-level interest but not an unequivocal buy. The report explicitly records MA as a large-cap growth company in Consumer Financial Services and shows PASS results for earnings predictability, return on equity, return on assets, free cash flow, use of retained earnings and share repurchases, while the initial rate-of-return screen FAILS, indicating a rich entry valuation. Passing core profitability and capital-allocation metrics implies durable, predictable earnings and conservative deployment of capital consistent with a Buffett-style long-term holding; free cash flow and buybacks provide direct shareholder-return support per the model. The failed initial rate-of-return tempers near-term upside and elevates valuation risk for new entrants. Sentiment from the ancillary signals is mildly positive (score 0.3) with low market-impact (0.25), suggesting limited immediate price movement from this report. The model nonetheless records a PASS on expected return, which frames Mastercard as an attractive long-term-quality name provided investors manage entry timing and valuation sensitivity.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment